May 17, 2012 (San Diego, California) — A 1-year randomized study of postmenopausal women who took the new oral selective estrogen-receptor modulator (SERM) ospemifene (Ophena, Shionogi) for ...
Successful Treatment of Metastatic Renal Cell Carcinoma With a Nonmyeloablative Allogeneic Peripheral-Blood Progenitor-Cell Transplant: Evidence for a Graft-Versus-Tumor Effect PURPOSE: Tamoxifen is ...
(a) The tumor shows focal glandular architecture along with solid areas (100×, H&E). (b, c) The solid component exhibits prominent lymphocytic infiltrate with tumor heterogeneity (100×, H&E). (d) The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results